WeVote
Log In

Bill

Bill

A 2188

Establishes requirements to evaluate certain people who are pregnant and who have given birth for preeclampsia.

2026-2027 Regular Session Introduced by Robert Karabinchak and 3 co-sponsors

New Jersey bill requires healthcare providers to evaluate pregnant and postpartum patients for preeclampsia to improve detection and reduce maternal complications.

Reported and Referred to Assembly Regulated Professions Committee
0
WeVote Research Nonpartisan
Bill Summary · A 2188

Legislative bill overview

Bill A 2188 mandates screening and evaluation protocols for pregnant individuals and postpartum patients to identify and monitor preeclampsia, a serious pregnancy complication characterized by high blood pressure and protein in urine. The bill establishes clinical requirements for healthcare providers to assess patients at risk and ensure appropriate medical intervention.

Why is this important

Preeclampsia affects 3-5% of pregnancies and remains a leading cause of maternal mortality and severe morbidity in the United States, with Black women experiencing disproportionately higher rates. Standardized evaluation requirements could improve early detection, prevent complications like eclampsia and organ damage, and reduce preventable maternal deaths and injuries.

Potential points of contention

  • Healthcare provider burden: Requirements may increase clinical workload and documentation demands, potentially raising healthcare costs without specified funding mechanisms
  • Scope of evaluation standards: Unclear whether the bill mandates specific tests, frequency of screening, or protocols, which could create implementation challenges and liability questions
  • Insurance and access disparities: Mandatory evaluations may create cost barriers for uninsured or underinsured pregnant individuals if not clearly covered by insurance requirements

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.